NPPA fixes cost of 45 medicine packs
The National Pharmaceutical Pricing Authority (NPPA) has fixed the price of 45 formulation packs, including those used for treating cancer, epilepsy, heartburn, eczema and bacterial infections.
“The NPPA has fixed / revised the prices in respect of 45 formulation packs under Drug Prices Control Order (DPCO) 2013,” the regulator said in a notification on its website. The companies whose drugs are included for price fixation includes drug majors such as erstwhile Ranbaxy (now Sun Pharmaceutical Industries), Torrent Pharmaceuticals, Abbott Healthcare, Glenmark and Cadila Healthcare, it added.
NPPA’s mandate is to fix/ revise the prices of controlled bulk drugs and formulations and to enforce prices and availability of the medicines in the country. It also monitors the prices of decontrolled drugs.